Helping The others Realize The Advantages Of HOIPIN-1
The primary finish position was the safety and tolerability of sifalimumab. Treatment-emergent adverse activities (AEs) and significant AEs (SAEs) as well as their severity, end result, and any partnership on the study medication have been recorded via the investigator through the entire review. AEs were being deemed more likely to be related to re